◆ 会议时间：2023年2月10-12日
◆ 会议地点：日本 名古屋市
◆ 会议简介：
2023年第45届日本造血和免疫细胞疗法学会(JSTCT)年会将于2023年2月10-12日在日本名古屋市举行。
日本造血和免疫细胞疗法学会(JSTCT)最早于1978年作为日本全国范围内一个友好讨论骨髓移植的会议，并于1980年改名为骨髓移植研究组，1996年更名为日本造血干细胞移植协会（JSTCT），2006年根据日本法律批准学会成为非政府组织。2021年学会更名为日本造血和免疫细胞疗法学会（英译：日本移植与细胞治疗学会）。JSTCT的宗旨是促进造血干细胞移植领域宣的研究，提高其结果和安全性，为患者和捐赠者的福祉做出贡献。JSTCT现拥有2,300多名成员，包括医生、护士、其他相关医疗人士、捐赠者和临床协调员、志愿者和制药公司等等。未经许可禁止复制摘录转载本站任何内容(国际医学会议网lingyuint.com)
第45回日本造血･免疫細胞療法学会 総会
45th JSTCT Annual Meeting (JSTCT2023) Japanese Society for Transplantation and Cellular Therapy
时间/Date: February 10 (Fri.) – 12(Sun.), 2023
会场/Venue: 名古屋国際会議場-Nagoya Congress Center, Japan
主题/Theme: Let's get excited about new technologies in transplantation and cell therapy
摘要征文投稿：
演題募集期間： 7月25日（月）正午～9月26日（月）23:59まで再延長しました
Welcome Message
On behalf of the Japan Society for Transplantation and Cell Therapy (JTCT), it is my great pleasure and honor to host the 45th JSTCT Annual Meeting on February 10th-12th, 2023, at the Nagoya Congress Center, Nagoya, Japan. This is the 7th congress in Nagoya since the first congress back in 1978. The theme for the congress was set as "Let's get excited about new technologies in transplantation and cell therapy." From the dawn of bone marrow transplantation until now, there have been a lot of critical breakthroughs such as the introduction of cyclosporin, the development of various donor sources, non-myeloablative regimens, post-transplant cyclophosphamide, mesenchymal stem cell, and chimeric antigen receptor T-cells. Recently, the advent of single-cell analysis by taking advantage of single-cell sequencing and AI-related multidimensional analyses made it possible to trace the individual cell fate in various situations at a much higher level than ever. We are witnessing such an exciting moment now. We plan a symposium where attendees will be able to experience the transitional moment to the next stage where such technologies will solve the mechanism of therapeutic effect and adverse events following transplantation and cell therapy. We will invite frontline researchers from both home and abroad for most of the symposium and plan a sufficient timeframe for a hot panel discussion. Furthermore, an interactive discussion among speakers and attendees will be provided for the Pro/Con sessions and workshops. As online lectures have reduced the limitation of time difference and distance worldwide, opportunities to discuss with more foreign speakers will be organized for plans for co-medicals using simultaneous interpreting. We, members of the program committee and congress office, sincerely expect as many attendees as possible to get excited, learn, and be satisfied through the programs mentioned above.
JSTCT2023 President
Yoshiki Akatsuka
(Designated professor, Department of Immunology,
Nagoya University Graduate School of Medicine)
◆ 参会对象：医生、药剂师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
